Persante Health Care, a prominent leader in the national sleep management landscape, has officially announced the appointment of Bretton Lane, BS, RPSGT, to the dual role of president and chief growth officer. This strategic leadership move marks a significant milestone for the organization as it looks to solidify its market share, enhance its home sleep testing (HST) infrastructure, and aggressively evaluate emerging diagnostic technologies.
Lane, a highly respected figure in the sleep medicine community, brings a wealth of operational expertise to the Persante executive team. Her arrival signals a pivot toward high-growth initiatives, designed to better support the evolving needs of hospitals, health systems, large-scale physician practices, and independent sleep centers across the United States.
Main Facts: A Strategic Leadership Shift
The appointment of Bretton Lane is not merely a staffing decision; it is a clear indicator of Persante’s intent to scale its operations in an increasingly digital and home-centric healthcare environment. As president and chief growth officer, Lane is tasked with a tripartite mandate:
- Scaling Home Sleep Testing (HST): With the shift toward value-based care and patient-centric diagnostics, Lane will lead the expansion of Persante’s home sleep testing capabilities to reach more patients outside of traditional laboratory settings.
- Strategic Program Development: Lane will oversee the architecture of new service lines, ensuring that Persante remains at the cutting edge of sleep health solutions.
- Technology Integration: The organization is tasked with identifying and vetting emerging technologies—ranging from AI-driven data analytics to advanced diagnostic hardware—to improve clinical outcomes and operational efficiency.
Lane’s background as a Registered Polysomnographic Technologist (RPSGT) provides her with a rare, ground-up perspective on the field, bridging the gap between clinical reality and high-level executive strategy.
Chronology: The Path to Persante
Bretton Lane’s professional trajectory has been defined by rapid organizational scaling and an ability to navigate the complex regulatory and operational hurdles of the sleep medicine sector.
- The BetterNight Era: Lane’s most recent tenure was as president of BetterNight. During her time with the organization, she was instrumental in managing an unprecedented period of growth. She oversaw the company’s expansion from a modest team of approximately 20 employees to a robust workforce of nearly 450.
- Operational Oversight: At BetterNight, Lane’s purview was expansive. She directed operations across multiple pillars of sleep medicine, including comprehensive sleep diagnostics, virtual care platforms, the procurement and management of durable medical equipment (DME), dental sleep medicine, and large-scale population health initiatives.
- The Transition: Following her tenure at BetterNight, Lane’s decision to join Persante was characterized by a search for an organization with both a "strong foundation" and a "clear vision."
- The Appointment: In the current calendar year, Persante officially welcomed Lane, integrating her into the executive leadership team to build upon the company’s existing momentum and geographic reach.
Supporting Data: The Current State of the Sleep Industry
To understand the implications of Lane’s appointment, one must look at the data driving the sleep management market. The industry is currently undergoing a structural shift characterized by several key trends:
The Shift to Home Sleep Testing
Home sleep testing (HST) has transitioned from a niche offering to the standard of care for many patients suspected of having Obstructive Sleep Apnea (OSA). According to recent industry benchmarks, the cost-effectiveness of HST compared to in-lab polysomnography has forced providers to innovate. Persante is positioning itself to lead this transition, ensuring that their HST programs provide the same level of clinical rigor as a traditional sleep lab.
Virtual Care and Telehealth
The pandemic accelerated the adoption of virtual care, and it is no longer an optional service for sleep management providers. Patients now expect seamless digital integration—from scheduling and device setup to follow-up consultations. Lane’s experience in overseeing virtual care operations at her previous organization makes her an ideal architect for Persante’s future digital roadmaps.
Population Health Management
Sleep disorders are increasingly viewed as comorbidities that exacerbate other chronic conditions, such as hypertension, type 2 diabetes, and cardiovascular disease. By integrating sleep health into broader population health initiatives, companies like Persante are becoming vital partners for large health systems that are incentivized to reduce hospital readmissions and manage long-term patient health.
Official Responses: Leadership Vision
The transition has been met with enthusiasm from the top levels of Persante’s leadership. Vyto Kab, CEO of Persante, highlighted the necessity of Lane’s expertise in the current competitive climate.
"We’re excited to welcome Bretton to Persante," Kab said in a recent press statement. "She brings exceptional industry knowledge, proven leadership, and a passion for advancing sleep medicine. Bretton is joining an already exceptional management team, and we’re confident her experience will strengthen our organization, support our partners, and help build on the momentum we’ve created."
For her part, Lane emphasized that the move was calculated, driven by a belief in the long-term viability of the Persante model.
"Choosing the right opportunity mattered, and that’s why Persante stood out," Lane noted. "Joining one of the largest sleep management companies in the country, with a strong foundation, an exceptional team, and a clear vision for the future, made this an exciting next step in my career. With so much happening across the sleep industry, Persante is uniquely positioned to help shape what’s next, and I’m excited to be part of that journey."
Implications: What This Means for the Future of Sleep Medicine
The appointment of an executive with Lane’s specific background has profound implications for the trajectory of Persante Health Care and the broader sleep medicine market.
1. Enhanced Clinical Excellence and Regulatory Compliance
In an era of increasing scrutiny regarding diagnostic accuracy and patient data privacy, Lane’s mandate to reinforce "clinical excellence and regulatory compliance" is crucial. As sleep medicine moves into the home, maintaining the integrity of diagnostic data becomes significantly more difficult. Lane’s expertise suggests that Persante will likely implement more rigorous audit processes and quality control measures to ensure that home-based tests hold up under clinical review.
2. Strategic Partnerships and Market Consolidation
Persante is already one of the largest players in the national market, and Lane’s role as Chief Growth Officer suggests an intent to deepen existing partnerships. Hospitals and health systems are currently looking for "turnkey" solutions for sleep medicine that minimize their administrative burden. By strengthening these partnerships, Persante is positioning itself as the "outsourced department" of choice for major healthcare entities.
3. Evaluating "Next-Gen" Technologies
The inclusion of "evaluating emerging technologies" in Lane’s job description is telling. The sleep industry is currently seeing a surge in wearables, non-contact monitoring devices, and AI-driven automated scoring for sleep studies. Lane’s task is to filter through this noise and identify which technologies offer genuine clinical value versus those that are merely marketing trends. If Persante successfully adopts the right technologies, it could significantly lower the cost of per-study diagnostics while increasing throughput.
4. Patient-Centric Innovation
Ultimately, the goal of these organizational changes is to address the massive, unmet demand for sleep disorder treatment. With millions of Americans suffering from undiagnosed sleep apnea, the focus on expanding access through home testing and virtual care is a humanitarian imperative as much as a business strategy. Lane’s background in DME and patient-focused initiatives suggests that the patient experience will remain central to the company’s growth narrative.
Conclusion: A New Chapter for Persante
As Persante Health Care looks toward the future, the integration of Bretton Lane into its executive structure serves as a clear signal to the market. The organization is moving away from a purely service-based model and toward a technology-enabled, data-driven approach to sleep medicine.
By combining the scale and stability of a large national organization with the agility and innovative spirit of a leader who has navigated high-growth environments, Persante is well-positioned to remain at the vanguard of the sleep industry. Whether through the refinement of home sleep testing protocols or the adoption of breakthrough diagnostic technologies, the company is signaling that the next era of sleep health will be defined by efficiency, accessibility, and, above all, clinical excellence.
For industry observers and partners, the coming months will be telling. If Lane’s tenure at her previous organization is any indicator, Persante is likely to enter a period of aggressive expansion, further solidifying its role as a cornerstone of the American sleep medicine ecosystem.
